BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• BioMidwest

  HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron, available for pre-order on December 20th

  The first wearable blood pressure monitor comes in the form of a wrist watch and is an FDA-reviewed medical device

  December 20, 2018

   · 

  3 min read
• Business

  Frelii Appoints Seasoned Expert as New Board Member to Support Growth & Expand Strategic Positioning

  Frelii Inc. announced the appointment of Leslie M. Norris to its Board of Directors (the “Board”), effective December 12, 2018.

  December 20, 2018

   · 

  4 min read
• Bio NC

  TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference

  TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California.

  December 20, 2018

   · 

  1 min read
• Business

  Evox Therapeutics Appoints Edwin Moses as Non-Executive Chairman

  Highly experienced life sciences executive with a track record of overseeing strong company growth and value creation

  December 20, 2018

   · 

  3 min read
• Policy

  The Obesity Society Updates Position on Obesity

  New Statement Focuses on Obesity as a Chronic Disease

  December 20, 2018

   · 

  4 min read
• Business

  Be The Match BioTherapies® Announces Collaboration with National Health Service Blood and Transplant of the United Kingdom

  Collaboration aims to streamline access to authorized collection and processing centers

  December 20, 2018

   · 

  4 min read
• Business

  Apexigen Announces Clinical Collaboration On A New Phase 2 Trial For APX005M In Sarcoma

  Apexigen today announced a collaboration with Columbia University Irving Medical Center on a new Phase 2 study for its lead immuno-oncology (I-O) therapeutic APX005M, a monoclonal antibody targeting CD40, in combination with doxorubicin and olaratumab in patients with advanced sarcomas.

  December 20, 2018

   · 

  3 min read
• Drug Development

  Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment

  Viriom, Inc. announced that it has initiated the first Phase 1 clinical trial of the long acting nanoformulation of VM1500A in HIV-uninfected volunteers

  December 20, 2018

   · 

  6 min read
• Drug Development

  LYNPARZA® (olaparib) Meets Primary Endpoint in Phase 3 SOLO-3 Trial for the Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer

  AstraZeneca and Merck’s LYNPARZA Significantly Improved Objective Response Rate Compared to Chemotherapy in Platinum-Sensitive Relapsed Patients Who Had Two or More Prior Lines of Chemotherapy

  December 20, 2018

   · 

  15 min read